Protgen Ltd   Report issue

For profit Phase 2
Founded: Beijing China (2004)
Status: No NME R&D (2004)

Organization Overview

First Clinical Trial
2009
NCT01223924
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Protgen Ltd